Aortic Aneurysm

Global Aortic Aneurysm Market to Reach US$10.1 Billion by 2030

The global market for Aortic Aneurysm estimated at US$5.6 Billion in the year 2024, is expected to reach US$10.1 Billion by 2030, growing at a CAGR of 10.4% over the analysis period 2024-2030. Thoracic Aortic Aneurysm, one of the segments analyzed in the report, is expected to record a 11.7% CAGR and reach US$7.2 Billion by the end of the analysis period. Growth in the Abdominal Aortic Aneurysm segment is estimated at 7.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 14.4% CAGR

The Aortic Aneurysm market in the U.S. is estimated at US$1.5 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 14.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.4% and 9.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR.

Global Aortic Aneurysm Market – Key Trends & Drivers Summarized

Why Is Aortic Aneurysm a Critical Cardiovascular Concern?

Aortic aneurysm is a life-threatening vascular condition characterized by the abnormal dilation or bulging of the aorta, the body`s largest blood vessel. If left untreated, an aortic aneurysm can rupture, leading to severe internal bleeding and a high risk of mortality. The condition is primarily classified into two types: abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA), with AAA being more prevalent, especially among aging populations. Factors such as hypertension, smoking, high cholesterol, and genetic predisposition contribute significantly to the development of aortic aneurysms. The rise in sedentary lifestyles, obesity, and diabetes is further exacerbating the prevalence of aortic aneurysms globally. Advancements in diagnostic imaging, including computed tomography angiography (CTA), magnetic resonance angiography (MRA), and ultrasound, have significantly improved early detection rates, allowing for timely intervention. However, the asymptomatic nature of the condition in its early stages makes screening programs crucial in high-risk demographics. Governments and healthcare organizations are increasingly focusing on awareness campaigns and routine screening for at-risk individuals, particularly males over 65 and individuals with a family history of aneurysms. The increasing burden of cardiovascular diseases (CVDs) has placed aortic aneurysm management at the forefront of modern cardiology, necessitating continued innovation in early detection, monitoring, and treatment.

How Are Technological Advancements Transforming Aortic Aneurysm Treatment?

Innovations in medical technology have revolutionized the diagnosis, monitoring, and treatment of aortic aneurysms, leading to better patient outcomes and reduced mortality rates. One of the most significant advancements in recent years has been the widespread adoption of endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR) techniques, which have largely replaced traditional open surgical procedures. These minimally invasive procedures involve the placement of stent grafts inside the aorta to reinforce weakened vessel walls, significantly reducing recovery time, hospital stays, and post-operative complications. In addition to procedural innovations, the integration of artificial intelligence (AI) and machine learning (ML) in imaging diagnostics is enhancing the precision and efficiency of aneurysm detection, risk stratification, and surgical planning. Furthermore, 3D printing technology is enabling the creation of patient-specific anatomical models, allowing surgeons to plan and customize interventions with greater accuracy. The introduction of bioresorbable stents, which gradually dissolve after serving their purpose, represents another breakthrough in aneurysm management. Continuous research into next-generation biomaterials and drug-eluting stents is also driving the evolution of aneurysm treatment by improving vascular healing and reducing the risk of complications such as endoleaks. As technological advancements continue to shape the landscape of aortic aneurysm care, personalized medicine and precision treatment strategies are emerging as key trends in the management of this condition.

What Market Trends Are Driving the Demand for Aortic Aneurysm Treatments?

The increasing global prevalence of aortic aneurysms, coupled with advancements in healthcare infrastructure, is driving a significant rise in demand for innovative treatment solutions. One of the most prominent trends shaping the market is the shift toward minimally invasive interventions, with EVAR and TEVAR gaining widespread acceptance as the standard of care due to their lower risk profiles and faster recovery times compared to open surgery. Additionally, the rise of telemedicine and remote monitoring solutions is enabling more effective post-operative care and long-term aneurysm surveillance, reducing the likelihood of complications. The growing adoption of wearable cardiovascular monitoring devices and AI-powered predictive analytics is further improving the management of high-risk patients by allowing for early detection of aneurysm progression. In parallel, regulatory bodies such as the FDA and the European Medicines Agency (EMA) are streamlining approval processes for novel aneurysm repair devices, facilitating faster market entry for next-generation stents and grafts. Emerging economies, particularly in Asia-Pacific and Latin America, are witnessing increased investments in cardiovascular care, leading to greater accessibility to aneurysm screening programs and advanced treatment modalities. Additionally, the growing collaboration between medical device manufacturers, research institutions, and healthcare providers is fostering innovation in aortic aneurysm treatment, paving the way for more efficient, patient-centered solutions.

What Are the Key Growth Drivers Fueling the Aortic Aneurysm Market?

The growth in the aortic aneurysm market is driven by several factors, including technological advancements in stent grafts and minimally invasive procedures, increasing awareness and screening programs, and the rising global burden of cardiovascular diseases. The expanding adoption of EVAR and TEVAR procedures, fueled by their proven benefits in reducing surgical risks and improving patient recovery, is significantly contributing to market expansion. Additionally, the integration of AI-driven diagnostic imaging and predictive analytics is enhancing early detection and treatment planning, leading to better clinical outcomes. The growing demand for patient-specific, customized stent grafts is driving innovation in medical device manufacturing, with 3D printing and advanced biomaterials playing a crucial role in product development. The increasing presence of hybrid operating rooms equipped with cutting-edge imaging technologies is further enabling complex aortic aneurysm procedures to be performed with greater precision and safety. Furthermore, the rising focus on value-based healthcare and cost-effective treatment options is prompting healthcare providers to invest in long-term aneurysm surveillance solutions, including remote monitoring and AI-powered risk assessment tools. The increasing prevalence of lifestyle-related risk factors, coupled with an aging population, is also contributing to a higher incidence of aortic aneurysms, reinforcing the need for continuous advancements in prevention, diagnosis, and treatment. As the market continues to evolve, the convergence of technological innovation, regulatory support, and patient-centered care is expected to drive sustained growth in the global aortic aneurysm treatment landscape.

SCOPE OF STUDY:

The report analyzes the Aortic Aneurysm market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Thoracic Aortic Aneurysm, Abdominal Aortic Aneurysm); Treatment (Open Surgical Repair, Endovascular Aneurysm Repair); Product (Stent Grafts, Catheters); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Clinics End-Use)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

• AbbVie Inc.
• Aptus Endosystems Inc.
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Cardiatis S.A.
• Cardinal Health Inc.
• CONMED Corporation
• Cook Medical Inc.
• CryoLife Inc.
• Endologix LLC
• Endospan Ltd.
• Getinge AB
• Johnson & Johnson Services Inc.
• JOTEC GmbH
• LeMaitre Vascular Inc.
• LifeTech Scientific Corporation
• Lombard Medical Limited
• Medtronic plc

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.